Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.


  • Molecular trigger for cerebral cavernous malformation identified

  • Researchers urge caution in prescribing commonly used drug to treat ADHD

  • Even the elderly can recover from a severe traumatic brain injury

  • Instrument to measure brand embarrassment developed by economists

  • White matter damage caused by 'skunk-like' cannabis, study shows

  • Cognitive behavior therapy can help overcome fear of the dentist

  • How can I tell if they're lying?

  • Amblyopia, not strabismus, identified as key contributor to slow reading in school-age children

  • Visual stress could be a symptom of Chronic Fatigue Syndrome, research suggests

  • Lower availability of omega-3 fatty acids in the body associated with bipolar disorder